Is this page useful for you? Then, help us to keep the service working. Please have a look to our donations page ... Thanks for your help!!

PharmacoEconomics / Springer

0.25

Impact Factor

0.19

5-Years IF

7

5-Years H index

Main indicators

Raw data

IF AIF IF5 DOC CDO CCU CIF CIT D2Y C2Y D5Y C5Y %SC CiY II AII
19900.1000 (%)0.04
19910.09000 (%)0.04
19920.1000 (%)0.04
19930.11000 (%)0.05
19940.12000 (%)0.05
19950.19000 (%)0.07
19960.22000 (%)0.09
19970.271010400 (%)0.09
19980.27122221010 (%)0.1
19990.312240.182222 (%)0.13
20000.40.0593110.031122211 (100%)0.15
20010.4334931 (%)0.15
20020.42341234 (%)0.18
20030.4453910.03324 (%)0.18
20040.4914010.031517 (%)0.2
20050.5374710.022618 (%)0.21
20060.516210910.01268161 (3.8%)0.2
20070.030.440.033814730.026692752 (%)0.18
20080.472216937100113 (%)0.2
20090.4728197360130 (%)0.19
20100.040.440.033323050.021350215741 (7.7%)0.16
20110.020.510.033226250.022461118353 (12.5%)0.2
20120.080.560.0787349170.0522655153114 (18.2%)10.010.21
20130.090.660.0896445330.0782119112021746 (56.1%)70.070.23
20140.130.670.11123568760.1373183242763010 (13.7%)190.150.22
20150.250.820.191056731050.161921954371718 (42.1%)90.090.27
IF: Impact Factor: C2Y / D2Y
AIF: Average Impact Factor for series in RePEc in year y
IF5: Impact Factor: C5Y / D5Y
DOC: Number of documents published in year y
CDO: Cumulative number of documents published until year y
CCU: Cumulative number of citations to papers published until year y
CIF: Cumulative impact factor
CIT: Number of citations to papers published in year y
D2Y: Number of articles published in y-1 plus y-2
C2Y: Cites in y to articles published in y-1 plus y-2
D5Y: Number of articles published in y-1 until y-5
C5Y: Cites in y to articles published in y-1 until y-5
%SC: Percentage of selft citations in y to articles published in y-1 plus y-2
CiY: Cites in year y to documents published in year y
II: Immediacy Index: CiY / Documents.
AII: Average Immediacy Index for series in RePEc in year y

 

50 most cited documents in this series:

#YearTitleCited
12013Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement. (2013). Husereau, Don ; Briggs, Andrew ; Petrou, Stavros ; Drummond, Michael ; Mauskopf, Josephine ; Augustovski, Federico ; Loder, Elizabeth ; Moher, David ; Greenberg, Dan ; Carswell, Chris . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:361-367.

Full description at Econpapers || Download paper

51
22008Conducting Discrete Choice Experiments to Inform Healthcare Decision Making. (2008). Lancsar, Emily ; Louviere, Jordan . In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:661-677.

Full description at Econpapers || Download paper

26
32014Managing short-term capital flows in new central banking: unconventional monetary policy framework in Turkey. (2014). Aysan, Ahmet ; Fendoglu, Salih ; Kilinc, Mustafa . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:45-69.

Full description at Econpapers || Download paper

14
4Effects of Reference Pricing in Pharmaceutical Markets. (2011). Miraldo, Marisa ; Galizzi, Matteo ; Ghislandi, Simone . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:17-33.

Full description at Econpapers || Download paper

14
52014Effects of additional monetary tightening on exchange rates. (2014). Oduncu, Arif ; Taskin, Temel ; Ermisoglu, Ergun . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:71-79.

Full description at Econpapers || Download paper

11
62014Monetary policy challenges: how central banks changed their modus operandi. (2014). Giorgio, Giorgio . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:25-43.

Full description at Econpapers || Download paper

8
72014Japan’s monetary policy in a challenging environment. (2014). Shirai, Sayuri . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:3-24.

Full description at Econpapers || Download paper

8
82006Impacts of Cost Containment Strategies on Pharmaceutical Expenditures of the National Health Insurance in Taiwan, 1996–2003. (2006). Liu, Chien-Hsiang ; Lee, Yue-Chune ; Huang, Yu-Tung ; Chen, Sun-Bing ; Yang, Ming-Chin . In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:9:p:891-902.

Full description at Econpapers || Download paper

7
92014Discrete Choice Experiments in Health Economics: A Review of the Literature. (2014). Moro, Domenico ; Petrou, Stavros ; Clark, Michael ; Bekker-Grob, Esther ; Determann, Domino . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:9:p:883-902.

Full description at Econpapers || Download paper

7
102006The Effect of Using Newer Drugs on Admissions of Elderly Americans to Hospitals and Nursing Homes: State-level Evidence from 1997 to 2003. (2006). Lichtenberg, Frank. In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:3:p:5-25.

Full description at Econpapers || Download paper

5
112012Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France, 2001–7. (2012). Lichtenberg, Frank. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:3:p:197-211.

Full description at Econpapers || Download paper

5
122010International Comparison of Comparative Effectiveness Research in Five Jurisdictions. (2010). Levy, Adrian ; Johnston, Karissa ; Mitton, Craig ; Harrigan, Brian ; Briggs, Andrew . In: PharmacoEconomics. RePEc:spr:pharme:v:28:y:2010:i:10:p:813-830.

Full description at Econpapers || Download paper

4
13Overview of Parametric Survival Analysis for Health-Economic Applications. (2013). Kreif, Noemi ; Benedict, Agnes ; Muszbek, Noemi ; Ishak, K.. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:8:p:663-675.

Full description at Econpapers || Download paper

4
142014Self-employment against employment or unemployment: Markov transitions across the business cycle. (2014). Constant, Amelie ; Zimmermann, Klaus . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:51-87.

Full description at Econpapers || Download paper

3
152013Unravelling Drug Reimbursement Outcomes: A Comparative Study of the Role of Pharmacoeconomic Evidence in Dutch and Swedish Reimbursement Decision Making. (2013). Boer, Anthonius ; Franken, Margreet ; Koopmanschap, Marc ; Nilsson, Fredrik ; Sandmann, Frank . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:9:p:781-797.

Full description at Econpapers || Download paper

3
162008Generic Entry, Reformulations and Promotion of SSRIs in the US. (2008). Koss, Catherine ; Frank, Richard ; Donohue, Julie ; Huskamp, Haiden ; Berndt, Ernst . In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:7:p:603-616.

Full description at Econpapers || Download paper

3
172014Hedging China’s energy oil market risks. (2014). Lau, Marco ; Zhang, Zhe ; Tan, Na. In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:99-112.

Full description at Econpapers || Download paper

3
182012Common Drug Review Recommendations. (2012). Rocchi, Angela ; Goeree, Ron ; Hopkins, Robert ; Miller, Elizabeth . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:3:p:229-246.

Full description at Econpapers || Download paper

3
192006Generic Health-Related Quality-of-Life Assessment in Children and Adolescents. (2006). Nickel, Jennifer ; Ravens-Sieberer, Ulrike ; Wetzel, Ralf ; Wille, Nora ; Bullinger, Monika ; Erhart, Michael . In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:12:p:1199-1220.

Full description at Econpapers || Download paper

3
202012Does the EQ-5D Reflect Lost Earnings?. (2012). Tsuchiya, Aki ; Brouwer, Werner ; Kro, Marieke ; Brazier, John ; Exel, Job ; Tilling, Carl . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:1:p:47-61.

Full description at Econpapers || Download paper

3
21Influence of Pharmacogenomic Profiling Prior to Pharmaceutical Treatment in Metastatic Colorectal Cancer on Cost Effectiveness. (2013). Frank, Martin ; Mittendorf, Thomas . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:3:p:215-228.

Full description at Econpapers || Download paper

3
222011Do Productivity Costs Matter?. (2011). Brouwer, Werner ; Papenburg, Joce ; Krol, Marieke ; Koopmanschap, Marc . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:7:p:601-619.

Full description at Econpapers || Download paper

3
232014The Value of a QALY: Individual Willingness to Pay for Health Gains Under Risk. (2014). Brouwer, Werner ; Bobinac, Ana ; Exel, Job . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:1:p:75-86.

Full description at Econpapers || Download paper

3
242013How to Include Informal Care in Economic Evaluations. (2013). Brouwer, Werner ; Exel, Job ; Hoefman, Renske . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:12:p:1105-1119.

Full description at Econpapers || Download paper

3
252013How Much Should the NHS Pay for a QALY?. (2013). Haycox, Alan. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:357-359.

Full description at Econpapers || Download paper

3
262014Reconceptualising the External Validity of Discrete Choice Experiments. (2014). Swait, Joffre ; Lancsar, Emily. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:10:p:951-965.

Full description at Econpapers || Download paper

3
272014Can the Real Opportunity Cost Stand Up: Displaced Services, the Straw Man Outside the Room. (2014). Pekarsky, Brita ; Eckermann, Simon . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:319-325.

Full description at Econpapers || Download paper

3
281997Guidelines for Pharmacoeconomic Studies. (1997). Russell, Louise ; Luce, Bryan ; Weinstein, Milton ; Gold, Marthe ; Siegel, Joanna ; Torrance, George . In: PharmacoEconomics. RePEc:spr:pharme:v:11:y:1997:i:2:p:159-168.

Full description at Econpapers || Download paper

3
292008Assessing the Impact of Global Price Interdependencies. (2008). Richter, Anke . In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:649-659.

Full description at Econpapers || Download paper

3
302011Unit Costs for Delivery of Antiretroviral Treatment and Prevention of Mother-to-Child Transmission of HIV. (2011). Galarraga, Omar ; Figueroa-Lara, Alejandro ; Yared Santa-Ana-Tellez, ; Wirtz, Veronika ; Viisainen, Kirsi ; Coulibaly, Ibrahima ; Korenromp, Eline ; Medina-Lara, Antonieta . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:7:p:579-599.

Full description at Econpapers || Download paper

3
312015Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status. (2015). Cawley, John ; Wintfeld, Neil ; Biener, Adam ; Hammer, Mette . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:707-722.

Full description at Econpapers || Download paper

3
322014Are Current Cost-Effectiveness Thresholds for Low- and Middle-Income Countries Useful? Examples from the World of Vaccines. (2014). Newall, A. ; Hutubessy, R. ; Jit, M.. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:6:p:525-531.

Full description at Econpapers || Download paper

2
332010An Analysis of NICE’s ‘Restricted’ (or ‘Optimized’) Decisions. (2010). Devlin, Nancy ; ONeill, Phill . In: PharmacoEconomics. RePEc:spr:pharme:v:28:y:2010:i:11:p:987-993.

Full description at Econpapers || Download paper

2
342014A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials. (2014). Epstein, David ; Faria, Rita ; White, Ian . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:12:p:1157-1170.

Full description at Econpapers || Download paper

2
352010Financial Effects of Pharmaceutical Price Regulation on R&D Spending by EU versus US Firms. (2010). Vernon, John ; Golec, Joseph . In: PharmacoEconomics. RePEc:spr:pharme:v:28:y:2010:i:8:p:615-628.

Full description at Econpapers || Download paper

2
362014Solo self-employed versus employer entrepreneurs: determinants and macro-economic effects in OECD countries. (2014). Scholman, Gerard ; Wennekers, Sander . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:107-136.

Full description at Econpapers || Download paper

2
372013The Determinants of Cost-Effectiveness Potential: An Historical Perspective on Lipid-Lowering Therapies. (2013). Miraldo, Marisa ; McGrath, Clare ; Camejo, Rodrigo Refoios . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:445-454.

Full description at Econpapers || Download paper

2
382015Sipuleucel-T for the Treatment of Metastatic Hormone-Relapsed Prostate Cancer: A NICE Single Technology Appraisal; An Evidence Review Group Perspective. (2015). Wong, Ruth ; Simpson, Emma ; Davis, Sarah ; Thokala, Praveen ; Breeze, Penny ; Bryden, Peter . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:11:p:1187-1194.

Full description at Econpapers || Download paper

2
392011Availability of and Access to Orphan Drugs. (2011). Stargardt, Tom ; Schreyögg, Jonas ; Blankart, Carl ; Schreyogg, Jonas . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:63-82.

Full description at Econpapers || Download paper

2
402014Assessing the Value of Healthcare Interventions Using Multi-Criteria Decision Analysis: A Review of the Literature. (2014). Neasham, David ; Lanitis, Tereza ; Orfanos, Panagiotis ; Marsh, Kevin ; Caro, Jaime . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:345-365.

Full description at Econpapers || Download paper

2
412013Korean Guidelines for Pharmacoeconomic Evaluation (Second and Updated Version). (2013). Bae, Eun ; Jang, Sunmee ; Lee, SooOk . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:4:p:257-267.

Full description at Econpapers || Download paper

2
422006The Impact of Therapeutic Reference Pricing on Innovation in Cardiovascular Medicine. (2006). Sheridan, Desmond ; Attridge, Jim . In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:2:p:35-54.

Full description at Econpapers || Download paper

2
432015A Review and Classification of Approaches for Dealing with Uncertainty in Multi-Criteria Decision Analysis for Healthcare Decisions. (2015). Ijzerman, Maarten ; Broekhuizen, Henk ; Groothuis-Oudshoorn, Catharina ; Til, Janine ; Hummel, J.. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:5:p:445-455.

Full description at Econpapers || Download paper

2
442007Direct and Indirect Costs Attributable to Alcohol Consumption in Germany. (2007). Konnopka, Alexander ; Konig, Hans-Helmut . In: PharmacoEconomics. RePEc:spr:pharme:v:25:y:2007:i:7:p:605-618.

Full description at Econpapers || Download paper

2
452014How to Estimate Productivity Costs in Economic Evaluations. (2014). Brouwer, Werner ; Krol, Marieke . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:335-344.

Full description at Econpapers || Download paper

2
462014Health-Related Productivity Loss: NICE to Recognize Soon, Good to Discuss Now. (2014). Anis, Aslam ; Zhang, Wei . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:5:p:425-427.

Full description at Econpapers || Download paper

2
472005Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary disease. (2005). Briggs, Andrew ; Grossman, Ronald ; Spencer, Michael ; Rance, Laureen . In: PharmacoEconomics. RePEc:spr:pharme:v:23:y:2005:i:6:p:619-637.

Full description at Econpapers || Download paper

2
482014The probability of default in Russian banking. (2014). Kostrov, Alexander . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:81-98.

Full description at Econpapers || Download paper

2
492012What’s Good and Bad About Contraceptive Products?. (2012). Viney, Rosalie ; Knox, Stephanie ; Haas, Marion ; Fiebig, Denzil ; Bateson, Deborah ; Weisberg, Edith ; Street, Deborah . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:12:p:1187-1202.

Full description at Econpapers || Download paper

2
502014When to Use Discrete Event Simulation (DES) for the Economic Evaluation of Health Technologies? A Review and Critique of the Costs and Benefits of DES. (2014). Hossein Haji Ali Afzali, ; Karnon, Jonathan . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:6:p:547-558.

Full description at Econpapers || Download paper

2

50 most relevant documents in this series (papers most cited in the last two years)

#YearTitleCited
12013Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement. (2013). Husereau, Don ; Briggs, Andrew ; Petrou, Stavros ; Drummond, Michael ; Mauskopf, Josephine ; Augustovski, Federico ; Loder, Elizabeth ; Moher, David ; Greenberg, Dan ; Carswell, Chris . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:361-367.

Full description at Econpapers || Download paper

43
22008Conducting Discrete Choice Experiments to Inform Healthcare Decision Making. (2008). Lancsar, Emily ; Louviere, Jordan . In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:661-677.

Full description at Econpapers || Download paper

17
32014Managing short-term capital flows in new central banking: unconventional monetary policy framework in Turkey. (2014). Aysan, Ahmet ; Fendoglu, Salih ; Kilinc, Mustafa . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:45-69.

Full description at Econpapers || Download paper

14
42014Effects of additional monetary tightening on exchange rates. (2014). Oduncu, Arif ; Taskin, Temel ; Ermisoglu, Ergun . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:71-79.

Full description at Econpapers || Download paper

11
52011Effects of Reference Pricing in Pharmaceutical Markets. (2011). Miraldo, Marisa ; Galizzi, Matteo ; Ghislandi, Simone . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:17-33.

Full description at Econpapers || Download paper

10
62014Japan’s monetary policy in a challenging environment. (2014). Shirai, Sayuri . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:3-24.

Full description at Econpapers || Download paper

8
72014Monetary policy challenges: how central banks changed their modus operandi. (2014). Giorgio, Giorgio . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:25-43.

Full description at Econpapers || Download paper

8
82014Discrete Choice Experiments in Health Economics: A Review of the Literature. (2014). Moro, Domenico ; Petrou, Stavros ; Clark, Michael ; Bekker-Grob, Esther ; Determann, Domino . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:9:p:883-902.

Full description at Econpapers || Download paper

7
92012Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France, 2001–7. (2012). Lichtenberg, Frank. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:3:p:197-211.

Full description at Econpapers || Download paper

4
102010International Comparison of Comparative Effectiveness Research in Five Jurisdictions. (2010). Levy, Adrian ; Johnston, Karissa ; Mitton, Craig ; Harrigan, Brian ; Briggs, Andrew . In: PharmacoEconomics. RePEc:spr:pharme:v:28:y:2010:i:10:p:813-830.

Full description at Econpapers || Download paper

4
112014Can the Real Opportunity Cost Stand Up: Displaced Services, the Straw Man Outside the Room. (2014). Pekarsky, Brita ; Eckermann, Simon . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:319-325.

Full description at Econpapers || Download paper

3
122014Reconceptualising the External Validity of Discrete Choice Experiments. (2014). Swait, Joffre ; Lancsar, Emily. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:10:p:951-965.

Full description at Econpapers || Download paper

3
132006Impacts of Cost Containment Strategies on Pharmaceutical Expenditures of the National Health Insurance in Taiwan, 1996–2003. (2006). Liu, Chien-Hsiang ; Lee, Yue-Chune ; Huang, Yu-Tung ; Chen, Sun-Bing ; Yang, Ming-Chin . In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:9:p:891-902.

Full description at Econpapers || Download paper

3
142014Hedging China’s energy oil market risks. (2014). Lau, Marco ; Zhang, Zhe ; Tan, Na. In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:99-112.

Full description at Econpapers || Download paper

3
152013How to Include Informal Care in Economic Evaluations. (2013). Brouwer, Werner ; Exel, Job ; Hoefman, Renske . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:12:p:1105-1119.

Full description at Econpapers || Download paper

3
162011Unit Costs for Delivery of Antiretroviral Treatment and Prevention of Mother-to-Child Transmission of HIV. (2011). Galarraga, Omar ; Figueroa-Lara, Alejandro ; Yared Santa-Ana-Tellez, ; Wirtz, Veronika ; Viisainen, Kirsi ; Coulibaly, Ibrahima ; Korenromp, Eline ; Medina-Lara, Antonieta . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:7:p:579-599.

Full description at Econpapers || Download paper

3
172014The Value of a QALY: Individual Willingness to Pay for Health Gains Under Risk. (2014). Brouwer, Werner ; Bobinac, Ana ; Exel, Job . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:1:p:75-86.

Full description at Econpapers || Download paper

3
182013How Much Should the NHS Pay for a QALY?. (2013). Haycox, Alan. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:357-359.

Full description at Econpapers || Download paper

3
192013Overview of Parametric Survival Analysis for Health-Economic Applications. (2013). Kreif, Noemi ; Benedict, Agnes ; Muszbek, Noemi ; Ishak, K.. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:8:p:663-675.

Full description at Econpapers || Download paper

3
202014Self-employment against employment or unemployment: Markov transitions across the business cycle. (2014). Constant, Amelie ; Zimmermann, Klaus . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:51-87.

Full description at Econpapers || Download paper

3
212012Does the EQ-5D Reflect Lost Earnings?. (2012). Tsuchiya, Aki ; Brouwer, Werner ; Kro, Marieke ; Brazier, John ; Exel, Job ; Tilling, Carl . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:1:p:47-61.

Full description at Econpapers || Download paper

3
222013Unravelling Drug Reimbursement Outcomes: A Comparative Study of the Role of Pharmacoeconomic Evidence in Dutch and Swedish Reimbursement Decision Making. (2013). Boer, Anthonius ; Franken, Margreet ; Koopmanschap, Marc ; Nilsson, Fredrik ; Sandmann, Frank . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:9:p:781-797.

Full description at Econpapers || Download paper

3
232006Generic Health-Related Quality-of-Life Assessment in Children and Adolescents. (2006). Nickel, Jennifer ; Ravens-Sieberer, Ulrike ; Wetzel, Ralf ; Wille, Nora ; Bullinger, Monika ; Erhart, Michael . In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:12:p:1199-1220.

Full description at Econpapers || Download paper

3
242012Common Drug Review Recommendations. (2012). Rocchi, Angela ; Goeree, Ron ; Hopkins, Robert ; Miller, Elizabeth . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:3:p:229-246.

Full description at Econpapers || Download paper

3
252015Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status. (2015). Cawley, John ; Wintfeld, Neil ; Biener, Adam ; Hammer, Mette . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:707-722.

Full description at Econpapers || Download paper

3
262014How to Estimate Productivity Costs in Economic Evaluations. (2014). Brouwer, Werner ; Krol, Marieke . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:335-344.

Full description at Econpapers || Download paper

2
272010Financial Effects of Pharmaceutical Price Regulation on R&D Spending by EU versus US Firms. (2010). Vernon, John ; Golec, Joseph . In: PharmacoEconomics. RePEc:spr:pharme:v:28:y:2010:i:8:p:615-628.

Full description at Econpapers || Download paper

2
282015Sipuleucel-T for the Treatment of Metastatic Hormone-Relapsed Prostate Cancer: A NICE Single Technology Appraisal; An Evidence Review Group Perspective. (2015). Wong, Ruth ; Simpson, Emma ; Davis, Sarah ; Thokala, Praveen ; Breeze, Penny ; Bryden, Peter . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:11:p:1187-1194.

Full description at Econpapers || Download paper

2
292014Assessing the Value of Healthcare Interventions Using Multi-Criteria Decision Analysis: A Review of the Literature. (2014). Neasham, David ; Lanitis, Tereza ; Orfanos, Panagiotis ; Marsh, Kevin ; Caro, Jaime . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:345-365.

Full description at Econpapers || Download paper

2
302014When to Use Discrete Event Simulation (DES) for the Economic Evaluation of Health Technologies? A Review and Critique of the Costs and Benefits of DES. (2014). Hossein Haji Ali Afzali, ; Karnon, Jonathan . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:6:p:547-558.

Full description at Econpapers || Download paper

2
312013Influence of Pharmacogenomic Profiling Prior to Pharmaceutical Treatment in Metastatic Colorectal Cancer on Cost Effectiveness. (2013). Frank, Martin ; Mittendorf, Thomas . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:3:p:215-228.

Full description at Econpapers || Download paper

2
322014Authors’ Reply to Gandjour: “Are Current Cost-Effectiveness Thresholds for Low- and Middle-Income Countries Useful? Examples from the World of Vaccines”. (2014). Newall, A. ; Hutubessy, R. ; Jit, M.. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:12:p:1247-1247.

Full description at Econpapers || Download paper

2
332006The Effect of Using Newer Drugs on Admissions of Elderly Americans to Hospitals and Nursing Homes: State-level Evidence from 1997 to 2003. (2006). Lichtenberg, Frank. In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:3:p:5-25.

Full description at Econpapers || Download paper

2
342014Solo self-employed versus employer entrepreneurs: determinants and macro-economic effects in OECD countries. (2014). Scholman, Gerard ; Wennekers, Sander . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:107-136.

Full description at Econpapers || Download paper

2
352013Korean Guidelines for Pharmacoeconomic Evaluation (Second and Updated Version). (2013). Bae, Eun ; Jang, Sunmee ; Lee, SooOk . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:4:p:257-267.

Full description at Econpapers || Download paper

2
362014The probability of default in Russian banking. (2014). Kostrov, Alexander . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:81-98.

Full description at Econpapers || Download paper

2
372015A Review and Classification of Approaches for Dealing with Uncertainty in Multi-Criteria Decision Analysis for Healthcare Decisions. (2015). Ijzerman, Maarten ; Broekhuizen, Henk ; Groothuis-Oudshoorn, Catharina ; Til, Janine ; Hummel, J.. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:5:p:445-455.

Full description at Econpapers || Download paper

2
382008Generic Entry, Reformulations and Promotion of SSRIs in the US. (2008). Koss, Catherine ; Frank, Richard ; Donohue, Julie ; Huskamp, Haiden ; Berndt, Ernst . In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:7:p:603-616.

Full description at Econpapers || Download paper

2
392014Are Current Cost-Effectiveness Thresholds for Low- and Middle-Income Countries Useful? Examples from the World of Vaccines. (2014). Newall, A. ; Hutubessy, R. ; Jit, M.. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:6:p:525-531.

Full description at Econpapers || Download paper

2
402014Health-Related Productivity Loss: NICE to Recognize Soon, Good to Discuss Now. (2014). Anis, Aslam ; Zhang, Wei . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:5:p:425-427.

Full description at Econpapers || Download paper

2
412014A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials. (2014). Epstein, David ; Faria, Rita ; White, Ian . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:12:p:1157-1170.

Full description at Econpapers || Download paper

2

Citing documents used to compute impact factor 54:

YearTitle
2015Cost-effectiveness thresholds in health care: a bookshelf guide to their meaning and use. (2015). Culyer, Anthony. In: Working Papers. RePEc:chy:respap:121cherp.

Full description at Econpapers || Download paper

2015Organizational barriers associated with the implementation of national essential medicines policy: A cross-sectional study of township hospitals in China. (2015). Yang, Lianping ; ZHANG, XINPING ; Ferrier, Adamm J ; Liu, Chaojie . In: Social Science & Medicine. RePEc:eee:socmed:v:145:y:2015:i:c:p:201-208.

Full description at Econpapers || Download paper

2015The Interest Rate Corridor as a Macroprudential Tool to Mitigate Rapid Growth in Credits: Evidence from Turkey. (2015). Bulut, Umit. In: Theoretical and Applied Economics. RePEc:agr:journl:v:4(605):y:2015:i:4(605):p:133-144.

Full description at Econpapers || Download paper

2015The Interest Rate Corridor as a Macroprudential Tool to Mitigate Rapid Growth in Credits: Evidence from Turkey. (2015). Bulut, Umit . In: Theoretical and Applied Economics. RePEc:agr:journl:v:4(605):y:2015:i:4(605):p:135-146.

Full description at Econpapers || Download paper

2015The Interest Rate Corridor as a Macroprudential Tool to Mitigate Rapid Growth in Credits: Evidence from Turkey. (2015). Bulut, Umit . In: Theoretical and Applied Economics. RePEc:agr:journl:v:xxii:y:2015:i:4(605):p:133-144.

Full description at Econpapers || Download paper

2015A Systematic Review of Cost-Effectiveness Analyses of Drugs for Postmenopausal Osteoporosis. (2015). Boonen, Annelies ; Ben Sedrine, Wafa ; Silverman, Stuart ; Evers, Silvia ; Hiligsmann, Mickael ; Kanis, John ; Reginster, Jean-Yves ; Wyers, Caroline ; Ramaekers, Bram . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:3:p:205-224.

Full description at Econpapers || Download paper

2015Local health care expenditure plans and their opportunity costs. (2015). Schaffer, Sarah Karlsberg ; Walker, Andrew ; Devlin, Nancy ; Sussex, Jon . In: Health Policy. RePEc:eee:hepoli:v:119:y:2015:i:9:p:1237-1244.

Full description at Econpapers || Download paper

2015Effects of the Bank of Japan’s current quantitative and qualitative easing. (2015). Matsuki, Takashi ; Satoma, Katsuhiko ; Sugimoto, Kimiko . In: Economics Letters. RePEc:eee:ecolet:v:133:y:2015:i:c:p:112-116.

Full description at Econpapers || Download paper

2015What makes banking crisis resolution difficult? Lessons from Japan and the Nordic Countries. (2015). Diemer, Michael ; Vollmer, Uwe . In: Eurasian Economic Review. RePEc:spr:eurase:v:5:y:2015:i:2:p:251-277.

Full description at Econpapers || Download paper

2015.

Full description at Econpapers || Download paper

2015The safety trap – the financial market and macroeconomic consequences of the scarcity of safe assets. (2015). Horvath, Daniel ; Szini, Robert . In: Financial and Economic Review. RePEc:mnb:finrev:v:14:y:2015:i:1:p:111-138.

Full description at Econpapers || Download paper

2015Estimating Productivity Costs in Health Economic Evaluations: A Review of Instruments and Psychometric Evidence. (2015). Tang, Kenneth . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:1:p:31-48.

Full description at Econpapers || Download paper

2015Multi-criteria decision analysis for supporting the selection of medical devices under uncertainty. (2015). Ivlev, Ilya ; Kneppo, Peter ; Vacek, Jakub . In: European Journal of Operational Research. RePEc:eee:ejores:v:247:y:2015:i:1:p:216-228.

Full description at Econpapers || Download paper

2015Distribution strategy and movie performance: an empirical note. (2015). HASAN, IFTEKHAR ; Ciciretti, Rocco ; Waisman, Maya . In: Eurasian Economic Review. RePEc:spr:eurase:v:5:y:2015:i:1:p:179-187.

Full description at Econpapers || Download paper

2015Policy alternatives for the relationship between ECB monetary and financial policies and new member states. (2015). Jurek, Michal ; Marszalek, Pawel . In: Working papers. RePEc:fes:wpaper:wpaper112.

Full description at Econpapers || Download paper

2015Monetary policy transmission and shifts in financial intermediation. (2015). Yorukoglu, Mehmet ; Alper, Koray ; Kilin, Mustafa . In: BIS Papers chapters. RePEc:bis:bisbpc:83-24.

Full description at Econpapers || Download paper

2015Reserve option mechanism as a stabilizing policy tool: Evidence from exchange rate expectations. (2015). Fendoglu, Salih ; Değerli, Ahmet ; Deerli, Ahmet ; Fendolu, Salih . In: International Review of Economics & Finance. RePEc:eee:reveco:v:35:y:2015:i:c:p:166-179.

Full description at Econpapers || Download paper

2015Interest Rate Corridor and the Monetary Policy Stance. (2015). Kara, Hakan. In: CBT Research Notes in Economics. RePEc:tcb:econot:1513.

Full description at Econpapers || Download paper

2015What do new forms of finance mean for EM central banks?. (2015). Bank for International Settlements, . In: BIS Papers. RePEc:bis:bisbps:83.

Full description at Econpapers || Download paper

2015Examining Ways to Handle Non-Random Missingness in CEA through Econometric and Statistics Lenses. (2015). Jackie, Yenerall ; Paul, Estabrooks ; George, Davis ; Wen, You . In: 2015 AAEA & WAEA Joint Annual Meeting, July 26-28, San Francisco, California. RePEc:ags:aaea15:205690.

Full description at Econpapers || Download paper

2015Medicares use of cost-effectiveness analysis for prevention (but not for treatment). (2015). Chambers, James D. ; Neumann, Peter J. ; Cangelosi, Michael J.. In: Health Policy. RePEc:eee:hepoli:v:119:y:2015:i:2:p:156-163.

Full description at Econpapers || Download paper

2015Regulatorische Handhabung der selektiven Erstattung von Arzneimitteln in den ausgewählten Ländern England, Niederlande, Frankreich und Schweden. (2015). Wasem, Jurgen ; May, Uwe ; Grande, Frederic ; Walendzik, Anke ; Bauer, Cosima ; Weegen, Lennart . In: IBES Diskussionsbeiträge. RePEc:zbw:udewwd:211.

Full description at Econpapers || Download paper

2015Biological Therapies for the Treatment of Severe Psoriasis in Patients with Previous Exposure to Biological Therapy: A Cost-Effectiveness Analysis. (2015). Smith, Catherine ; Murphy, Ruth ; Sawyer, Laura ; Jackson, Karina ; Samarasekera, Eleanor ; Wonderling, David . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:2:p:163-177.

Full description at Econpapers || Download paper

2015Cost per DALY averted thresholds for low- and middle-income countries: evidence from cross country data. (2015). Lomas, James ; Claxton, Karl ; Ochalek, Jessica . In: Working Papers. RePEc:chy:respap:122cherp.

Full description at Econpapers || Download paper

2015Pricing of forthcoming therapies for hepatitis C in Europe: beyond cost-effectiveness?. (2015). Garattini, Livio ; Vooren, Katelijne ; Curto, Alessandro . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:16:y:2015:i:4:p:341-345.

Full description at Econpapers || Download paper

2015Does Including Informal Care in Economic Evaluations Matter? A Systematic Review of Inclusion and Impact of Informal Care in Cost-Effectiveness Studies. (2015). van Exel, Job ; Krol, Marieke ; Papenburg, Joce . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:2:p:123-135.

Full description at Econpapers || Download paper

2015Resource Modelling: The Missing Piece of the HTA Jigsaw?. (2015). Jahn, Beate ; Dixon, Simon ; Thokala, Praveen . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:3:p:193-203.

Full description at Econpapers || Download paper

2015Are We Lacking Economic Evaluations in Gastric Cancer Treatment?. (2015). El-Sedfy, Abraham ; Brar, Savtaj ; Coburn, Natalie ; Johnson, Ana ; Mahar, Alyson . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:2:p:83-87.

Full description at Econpapers || Download paper

2015Cost Effectiveness of Transcatheter Aortic Valve Replacement Compared with Medical Management or Surgery for Patients with Aortic Stenosis. (2015). Iannaccone, Andrea ; Marwick, Thomas . In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:13:y:2015:i:1:p:29-45.

Full description at Econpapers || Download paper

2015A Practical Guide for Using Registry Data to Inform Decisions About the Cost Effectiveness of New Cancer Drugs: Lessons Learned from the PHAROS Registry. (2015). Groot, Carin Uyl-de ; Blommestein, Hedwig ; Franken, Margreet . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:6:p:551-560.

Full description at Econpapers || Download paper

2015Cost Effectiveness of Dipeptidyl Peptidase-4 Inhibitors for Type 2 Diabetes. (2015). Chen, Yingyao ; Yu, Hao ; Geng, Jinsong ; Mao, Yiwei ; Zhang, Peng . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:6:p:581-597.

Full description at Econpapers || Download paper

2015Reply to Roberts et al.: CHEERS is Sufficient for Reporting Cost-Benefit Analysis, but May Require Further Elaboration. (2015). Carswell, Chris ; Husereau, Don ; Petrou, Stavros ; Drummond, Michael ; Mauskopf, Josephine ; Greenberg, Dan ; Augustovski, Federico ; Briggs, Andrew ; Moher, David ; Loder, Elizabeth . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:5:p:535-536.

Full description at Econpapers || Download paper

2015Cost-Utility Analysis of a Medication Review with Follow-Up Service for Older Adults with Polypharmacy in Community Pharmacies in Spain: The conSIGUE Program. (2015). Saez-Benito, Loreto ; Benrimoj, Shalom ; Jodar-Sanchez, Francisco ; Malet-Larrea, Amaia ; Martin, Jose ; Garcia-Mochon, Leticia ; del Amo, Lopez M. ; Martinez-Martinez, Fernando ; Gastelurrutia-Garralda, Miguel ; Garcia-Cardenas, Victoria ; Sabater-Hernandez, Daniel . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:6:p:599-610.

Full description at Econpapers || Download Bridging the Gap: Exploring the Barriers to Using Economic Evidence in Healthcare Decision Making and Strategies for Improving Uptake. (2015). Graves, Nicholas ; Merlo, Gregory ; Page, Katie ; Halton, Kate . In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:13:y:2015:i:3:p:303-309.

Full description at Econpapers || Download paper

2015Cost-effectiveness of nurse-based case management versus usual care for elderly patients with myocardial infarction: results from the KORINNA study. (2015). Leidl, Reiner ; Kuch, Bernhard ; Seidl, Hildegard ; Hunger, Matthias ; Meisinger, Christa ; Wende, Rupert ; Holle, Rolf . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:16:y:2015:i:6:p:671-681.

Full description at Econpapers || Download paper

2015A Systematic Review of Studies Evaluating the Cost Utility of Screening High-Risk Populations for Latent Tuberculosis Infection. (2015). Campbell, Jonathon ; Marra, Fawziah ; Sasitharan, Thenuga . In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:13:y:2015:i:4:p:325-340.

Full description at Econpapers || Download paper

2015Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement. (2015). Gray, Alastair ; Froud, Robert ; Oppe, Mark ; Longworth, Louise ; Dakin, Helen ; Rivero-Arias, Oliver ; Petrou, Stavros . In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:13:y:2015:i:5:p:437-443.

Full description at Econpapers || Download paper

2015A Checklist for Reporting Valuation Studies of Multi-Attribute Utility-Based Instruments (CREATE). (2015). Viney, Rosalie ; Feeny, David ; Devlin, Nancy ; Revicki, Dennis ; Krabbe, Paul ; Pickard, A ; Xie, Feng . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:8:p:867-877.

Full description at Econpapers || Download paper

2015Exploring the Use of Cost-Benefit Analysis to Compare Pharmaceutical Treatments for Menorrhagia. (2015). Sanghera, Sabina ; Roberts, Tracy ; Kai, Joe ; Gupta, Janesh . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:9:p:957-965.

Full description at Econpapers || Download paper

2015Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review. (2015). Laurence, Yoko ; Vassall, Anna ; Griffiths, Ulla . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:9:p:939-955.

Full description at Econpapers || Download paper

2015Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement. (2015). Gray, Alastair ; Froud, Robert ; Oppe, Mark ; Longworth, Louise ; Dakin, Helen ; Rivero-Arias, Oliver ; Petrou, Stavros . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:985-991.

Full description at Econpapers || Download paper

2015Pre-eclampsia Diagnosis and Treatment Options: A Review of Published Economic Assessments. (2015). Zakiyah, Neily ; Asselt, Antoinette ; Baker, Philip ; Postma, Maarten . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:1069-1082.

Full description at Econpapers || Download paper

2015The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration. (2015). Gray, Alastair ; Froud, Robert ; Oppe, Mark ; Longworth, Louise ; Dakin, Helen ; Rivero-Arias, Oliver ; Petrou, Stavros . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:993-1011.

Full description at Econpapers || Download paper

2015Development and Use of Disease-Specific (Reference) Models for Economic Evaluations of Health Technologies: An Overview of Key Issues and Potential Solutions. (2015). Frederix, Gerardus ; Ward, Robyn ; Dasbach, Erik . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:8:p:777-781.

Full description at Econpapers || Download paper

2015Cost-utility Analysis of Vertebroplasty versus Thoracolumbosacral Orthosis in the Treatment of Traumatic Vertebral Fractures. (2015). Yakhelef, Nadia ; Chabert, Emmanuel ; Mons, Antoine ; Peirera, Bruno ; Audibert, Martine . In: Working Papers. RePEc:hal:wpaper:halshs-01241824.

Full description at Econpapers || Download paper

2015A Systematic Review of the State of Economic Evaluation for Health Care in India. (2015). Chauhan, Akashdeep ; Jan, Stephen ; Angell, Blake ; Prinja, Shankar ; Gupta, Indrani . In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:13:y:2015:i:6:p:595-613.

Full description at Econpapers || Download paper

2015The Role of Information Provision in Economic Evaluations of Newborn Bloodspot Screening: A Systematic Review. (2015). Payne, Katherine ; Jones, Cheryl ; Dharni, Nimarta ; Ulph, Fiona ; Wright, Stuart . In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:13:y:2015:i:6:p:615-626.

Full description at Econpapers || Download paper

2015Health state utilities associated with attributes of treatments for hepatitis C. (2015). Feeny, David ; Devine, Mary ; Matza, Louis ; Sapra, Sandhya ; Dillon, John ; Kalsekar, Anupama ; Davies, Evan ; Jordan, Jessica ; Landrian, Amanda . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:16:y:2015:i:9:p:1005-1018.

Full description at Econpapers || Download paper

2015Same drugs, valued differently? Comparing comparators and methods used in reimbursement recommendations in Australia, Canada, and Korea. (2015). Bae, Green . In: Health Policy. RePEc:eee:hepoli:v:119:y:2015:i:5:p:577-587.

Full description at Econpapers || Download paper

2015A Primer on Marginal Effects—Part I: Theory and Formulae. (2015). Bergtold, Jason ; Onukwugha, Eberechukwu ; Jain, Rahul . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:1:p:25-30.

Full description at Econpapers || Download paper

2015Simulation and Matching-Based Approaches for Indirect Comparison of Treatments. (2015). Benedict, Agnes ; Proskorovsky, Irina ; Ishak, K.. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:6:p:537-549.

Full description at Econpapers || Download paper

2015A comparative study of the role of disease severity in drug reimbursement decision making in four European countries. (2015). de Boer, Anthonius ; Scharringhausen, Tessa ; Franken, Margreet ; Koopmanschap, Marc ; Stolk, Elly . In: Health Policy. RePEc:eee:hepoli:v:119:y:2015:i:2:p:195-202.

Full description at Econpapers || Download paper

2015European collaboration on relative effectiveness assessments: What is needed to be successful?. (2015). Goettsch, Wim ; Kleijnen, Sarah ; Kristensen, Finn Borlum ; Rdzany, Rafa ; van der Graaff, Martin ; Siviero, Paolo D. ; Bucsics, Anna ; Pavlovic, Mira ; Wieseler, Beate ; George, Elisabeth ; de Groot, Folkert ; Toenders, Wil . In: Health Policy. RePEc:eee:hepoli:v:119:y:2015:i:5:p:569-576.

Full description at Econpapers || Download paper

2015Attributes and weights in health care priority setting: A systematic review of what counts and to what extent. (2015). Lancsar, Emily ; Gu, Yuanyuan ; Donaldson, Cam ; Rg, James ; Ghijben, Peter . In: Social Science & Medicine. RePEc:eee:socmed:v:146:y:2015:i:c:p:41-52.

Full description at Econpapers || Download paper

Recent citations (cites in year: CiY)

Recent citations received in 2015
YearCiting document
2015Neural Network Estimators of Binary Choice Processes: Estimation, Marginal Effects and WTP. (2015). Bergtold, Jason ; Ramsey, Steven M. In: 2015 AAEA & WAEA Joint Annual Meeting, July 26-28, San Francisco, California. RePEc:ags:aaea15:205649.

Full description at Econpapers || Download paper

2015Reporting error in weight and its implications for bias in economic models. (2015). Cawley, John ; MacLean, Johanna Catherine ; Hammer, Mette ; Wintfeld, Neil . In: Economics & Human Biology. RePEc:eee:ehbiol:v:19:y:2015:i:c:p:27-44.

Full description at Econpapers || Download paper

2015An economy of scales: A selective review of obesitys economic causes, consequences, and solutions. (2015). Cawley, John. In: Journal of Health Economics. RePEc:eee:jhecon:v:43:y:2015:i:c:p:244-268.

Full description at Econpapers || Download paper

2015Assessing sufficient capability: A new approach to economic evaluation. (2015). Mitchell, Paul Mark ; Coast, Joanna ; Barton, Pelham M ; Roberts, Tracy E. In: Social Science & Medicine. RePEc:eee:socmed:v:139:y:2015:i:c:p:71-79.

Full description at Econpapers || Download paper

2015Unpaid work in health economic evaluations. (2015). Brouwer, Werner ; Krol, Marieke . In: Social Science & Medicine. RePEc:eee:socmed:v:144:y:2015:i:c:p:127-137.

Full description at Econpapers || Download paper

2015Is personalized medicine a panacea for health management? Some thoughts on its desirability. (2015). Rodriguez-Ibeas, Roberto ; Juarez-Castello, Carmelo ; Antoanzas, Fernando . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:16:y:2015:i:5:p:455-457.

Full description at Econpapers || Download paper

2015Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement. (2015). Gray, Alastair ; Froud, Robert ; Oppe, Mark ; Longworth, Louise ; Dakin, Helen ; Rivero-Arias, Oliver ; Petrou, Stavros . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:985-991.

Full description at Econpapers || Download paper

2015For a Step Change to Curb the Obesity Epidemic. (2015). Cremieux, Pierre-Yves ; Frois, Christian . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:613-617.

Full description at Econpapers || Download paper

2015Development and Use of Disease-Specific (Reference) Models for Economic Evaluations of Health Technologies: An Overview of Key Issues and Potential Solutions. (2015). Frederix, Gerardus ; Ward, Robyn ; Dasbach, Erik . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:8:p:777-781.

Full description at Econpapers || Download paper

Recent citations received in 2014
YearCiting document
2014Addressing elimination and selection by aspects decision rules in discrete choice experiments: does it matter?. (2014). Erdem, Seda ; Campbell, Danny ; Thompson, Carl . In: 2014 Annual Meeting, July 27-29, 2014, Minneapolis, Minnesota. RePEc:ags:aaea14:169839.

Full description at Econpapers || Download paper

2014Global Entrepreneurship Monitor The Netherlands 2013. (2014). van Stel, André ; Span, Tommy . In: Scales Research Reports. RePEc:eim:papers:h201407.

Full description at Econpapers || Download paper

2014The Willingness to Pay for a QALY: a Review of the Empirical Literature. (2014). Svensson, Mikael ; Ryen, Linda . In: Karlstad University Working Papers in Economics. RePEc:hhs:kaunek:0012.

Full description at Econpapers || Download paper

2014Editorial Volume 7(3). (2014). Schofield, Deborah J ; Shrestha, Rupendra ; Carter, Hannah E. In: International Journal of Microsimulation. RePEc:ijm:journl:v:7:y:2014:i:3:p:33-52.

Full description at Econpapers || Download paper

2014Life at a premium: considering an end-of-life premium in Value Based Reimbursement.. (2014). Culyer, Anthony ; Edlin, Richard ; Paulden, Mike ; O'Mahony, James . In: Working Papers. RePEc:lee:wpaper:1407.

Full description at Econpapers || Download paper

2014Monetary policy challenges: how central banks changed their modus operandi. (2014). Di Giorgio, Giorgio. In: Eurasian Economic Review. RePEc:spr:eurase:v:4:y:2014:i:1:p:25-43.

Full description at Econpapers || Download paper

2014Japan’s monetary policy in a challenging environment. (2014). Shirai, Sayuri . In: Eurasian Economic Review. RePEc:spr:eurase:v:4:y:2014:i:1:p:3-24.

Full description at Econpapers || Download paper

2014Managing short-term capital flows in new central banking: unconventional monetary policy framework in Turkey. (2014). Kilinc, Mustafa ; Fendoglu, Salih ; Aysan, Ahmet. In: Eurasian Economic Review. RePEc:spr:eurase:v:4:y:2014:i:1:p:45-69.

Full description at Econpapers || Download paper

2014Effects of additional monetary tightening on exchange rates. (2014). Taskin, Temel ; Oduncu, Arif ; Ermisoglu, Ergun ; Akcelik, Yasin. In: Eurasian Economic Review. RePEc:spr:eurase:v:4:y:2014:i:1:p:71-79.

Full description at Econpapers || Download paper

2014Hedging with mini gold futures: evidence from Korea. (2014). Park, Cheolho ; Yun, Youngjun . In: Eurasian Economic Review. RePEc:spr:eurase:v:4:y:2014:i:2:p:163-176.

Full description at Econpapers || Download paper

2014Is health care expenditure across Europe converging? Findings from the application of a nonlinear panel unit root test. (2014). Lau, Chi ; Pugalis, Lee ; Fung, Ka. In: Eurasian Business Review. RePEc:spr:eurasi:v:4:y:2014:i:2:p:137-156.

Full description at Econpapers || Download paper

2014Patterns of innovation and wage distribution. Do “innovative firms” pay higher wages? Evidence from Chile. (2014). Cirillo, Valeria. In: Eurasian Business Review. RePEc:spr:eurasi:v:4:y:2014:i:2:p:181-206.

Full description at Econpapers || Download paper

2014Does Diabetes Have an Impact on Health-State Utility? A Study of Asians in Singapore. (2014). Tai, E. ; Wang, P. ; Luo, Nan ; Thumboo, J. ; Vrijhoef, Hubertus . In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:7:y:2014:i:3:p:329-337.

Full description at Econpapers || Download paper

2014Modelling Technique, Structural Assumptions, Input Parameter Values: Which Has the Most Impact on the Results of a Cost-Effectiveness Analysis?. (2014). Mauskopf, Josephine . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:6:p:521-523.

Full description at Econpapers || Download paper

2014Economic Evaluation of Warfarin, Dabigatran, Rivaroxaban, and Apixaban for Stroke Prevention in Atrial Fibrillation. (2014). Hagen, Gunhild ; Wisloff, Torbjorn ; Klemp, Marianne . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:6:p:601-612.

Full description at Econpapers || Download paper

2014Monetary policy challenges: how central banks changed their modus operandi. (2014). Giorgio, Giorgio . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:25-43.

Full description at Econpapers || Download paper

2014Japan’s monetary policy in a challenging environment. (2014). Shirai, Sayuri . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:3-24.

Full description at Econpapers || Download paper

2014Managing short-term capital flows in new central banking: unconventional monetary policy framework in Turkey. (2014). Aysan, Ahmet ; Fendoglu, Salih ; Kilinc, Mustafa . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:45-69.

Full description at Econpapers || Download paper

2014Effects of additional monetary tightening on exchange rates. (2014). Oduncu, Arif ; Taskin, Temel ; Ermisoglu, Ergun . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:71-79.

Full description at Econpapers || Download paper

Recent citations received in 2013
YearCiting document
2013Personalised medicine as a challenge for public pricing and reimbursement authorities – A survey among 27 European countries on the example of trastuzumab. (2013). Mantel-Teeuwisse, A. K. ; Vogler, S. ; Espin, J. ; Leopold, C. ; Habl, C.. In: Health Policy. RePEc:eee:hepoli:v:113:y:2013:i:3:p:313-322.

Full description at Econpapers || Download paper

2013Leasing health technologies- an affordable and effective reimbursement strategy for innovative technologies?. (2013). McCabe, Christopher ; Wallner, Klemens ; Edlin, Richard ; Hall, Peter . In: Working Papers. RePEc:lee:wpaper:1302.

Full description at Econpapers || Download paper

2013Use of Bayesian Markov Chain Monte Carlo Methods to Estimate EQ-5D Utility Scores from Eortic QLQ Data in Myeloma for Use in Cost effectiveness Analysis. (2013). McCabe, Christopher ; Browne, Chantelle ; Kharroubi, Samer A ; Edlin, Richard ; Meads, David . In: Working Papers. RePEc:lee:wpaper:1308.

Full description at Econpapers || Download paper

2013Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. (2013). Husereau, Don ; Briggs, Andrew ; Petrou, Stavros ; Drummond, Michael ; Mauskopf, Josephine ; Augustovski, Federico ; Loder, Elizabeth ; Moher, David ; Greenberg, Dan ; Carswell, Chris . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:14:y:2013:i:3:p:367-372.

Full description at Econpapers || Download paper

2013Assessing the Cost Effectiveness of Pre-Exposure Prophylaxis for HIV Prevention in the US. (2013). Hellinger, Fred . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:12:p:1091-1104.

Full description at Econpapers || Download paper

2013How Much Should the NHS Pay for a QALY?. (2013). Haycox, Alan. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:357-359.

Full description at Econpapers || Download paper

2013Good Practice Guidelines for the use of Statistical Regression Models in Economic Evaluations. (2013). Wailoo, Allan ; Ara, Roberta ; Alava, Monica ; Campbell, Mike ; Abrams, Keith ; Kearns, Ben ; Manca, Andrea . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:8:p:643-652.

Full description at Econpapers || Download paper

Recent citations received in 2012
YearCiting document
2012The Authors’ Reply. (2012). Delwel, Gepke ; Hoomans, Ties ; Roer, Nicole ; Severens, Johan . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:10:p:980-980.

Full description at Econpapers || Download paper

Warning!! This is still an experimental service. The results of this service should be interpreted with care, especially in research assessment exercises. The processing of documents is automatic. There still are errors and omissions in the identification of references. We are working to improve the software to increase the accuracy of the results.

Source data used to compute the impact factor of RePEc series.

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated December, 1 2016. Contact: CitEc Team